RedHill Biopharma (RDHL) has released an update.
RedHill Biopharma Ltd. recently held its Annual General Meeting, with shareholders approving all proposed resolutions. Key decisions include the appointment of Kesselman & Kesselman as auditors for 2024, the re-election of two board members alongside a new member, and the approval of restricted share units for non-executive directors, the CEO, and the Chief Commercial Officer.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.
